Skip to main content

precision medicine

By Dave Muoio | 01:28 pm | September 08, 2020
The health research platform has already helped enroll 356,000 participants into the nationwide research program.
By Dave Muoio | 03:52 pm | July 29, 2020
The roughly three-year-old company says it now has a post-money valuation over $1 billion.
By HIMSS TV | 09:06 am | May 14, 2020
Joel Diamond, MD, CMO of 2bPrecise, discusses pharmacogenomics as a good entry point for providers in precision medicine, identifying the right medicine for better outcomes and patient satisfaction.
By HIMSS TV | 10:02 am | April 14, 2020
Deep Dive: By integrating social factors, genomics and medical histories, clinicians are better able to treat patients.
SPONSORED
By PsychU | PsychU | 04:02 pm | April 07, 2020
The advantages to health and human service delivery in a bot workforce include speed, reliability, consistency and cost-effectiveness. Sound too far-fetched for your management team? We would disagree.  
By Laura Lovett | 02:18 pm | November 08, 2019
Insights into personalized genomics can help prevent diseases in outer space. 
By HIMSS TV | 12:04 am | October 11, 2019
DayTwo's metagenomics and gut microbiome database helps connect diabetics and others with evidence-based "food-as-medicine" treatment regimens, explains Josh Stevens, the company's president.
By HIMSS TV | 09:44 am | September 24, 2019
Mark Jackson, VP at NantHealth, was at Health 2.0 looking for new opportunities to bring valuable cloud-based data to physicians at the point of care.
By Dave Muoio | 02:33 pm | September 19, 2019
The Series A round will help the startup push into new therapeutic areas while fleshing out its integration capabilities.
By Leontina Postelnicu | 06:49 am | August 30, 2019
An interview with Hakim Yadi, chief executive and cofounder of Closed Loop Medicine.